The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up
Table 2
(a) Number of patients experiencing high grade (Gr 3-4) interferon-related hematologic toxicity during any phase of therapy (). (b) Number of patients with high grade (Gr 3-4) interferon-related non-hematologic toxicity reported during any phase of therapy ().
